Xlife Sciences AG (XLS) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Xlife Sciences AG

BRIEF

published on 12/01/2025 at 07:05, 3 days 22 hours ago

Xlife Sciences AG Unveils NeuroMex for Early Alzheimer’s Detection

Healthcare Innovation Xlife Sciences Market Opportunity NeuroMex Alzheimer’s Detection
PRESS RELEASE

published on 12/01/2025 at 07:00, 3 days 22 hours ago

Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity
Xlife Sciences AG and saniva diagnostics GmbH announce NeuroMex, the world's first certified medical device for early Alzheimer's detection, with 83.5% accuracy in identifying early-stage Alzheimer's

Healthcare Clinical Trials Xlife Sciences AG Alzheimer's Detection NeuroMex
BRIEF

published on 11/28/2025 at 13:15, 6 days 16 hours ago

Xlife Sciences AG Updates on VERAXA Biotech's NASDAQ Listing

Nasdaq Listing Business Combination SEC Filing Oncology Therapeutics VERAXA Biotech
PRESS RELEASE

published on 11/28/2025 at 13:10, 6 days 16 hours ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 1 month 19 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 1 month 19 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF

published on 09/23/2025 at 07:05, 2 months 11 days ago

Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025

Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
PRESS RELEASE

published on 09/23/2025 at 07:00, 2 months 11 days ago

Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025

Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF

published on 07/17/2025 at 07:05, 4 months 18 days ago

VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing

Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE

published on 07/17/2025 at 07:00, 4 months 18 days ago

Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey

Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4

1 2 ... 7

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 50 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 55 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 25 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 20 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 25 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 34 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 10 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 25 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 40 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 24 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE